JANET MONTES DE OCA-CORONA: Open Payments
NPI 1902579790 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,385 in 51 payments from 17 companies in 2025. Trend: 2023 $1,638 · 2024 $2,111 · 2025 $1,385
Food & beverage: $1,385
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $168 |
| Edwards Lifesciences Corporation | 1 | $161 |
| PFIZER INC. | 6 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $127 |
| Novartis Pharmaceuticals Corporation | 6 | $121 |
| Merck Sharp & Dohme LLC | 6 | $115 |
| Amgen Inc. | 6 | $112 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $73 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
Products named: PASCAL, JARDIANCE, REPATHA, Ozempic, LEQVIO, VYNDAQEL, VERQUVO, LifeVest.
Industry payments across IL — which companies pay providers there.
